SCHEMBL19484183

SCHEMBL19484183

CCNCC(C)(C)CNC(=O)c1cc(OC)on1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.39
SMN1; SMN2 Q16637 7/20 0.39
NPC1 O15118 5/20 0.39
TP53 P04637 2/20 0.39
ALDH1A1 P00352 3/20 0.38
HPGD P15428 4/20 0.38
KMT2A Q03164 1/20 0.38
GAA P10253 1/20 0.38
CYP2C19 P33261 1/20 0.38
HSD17B10 Q99714 3/20 0.37
MAPK1 P28482 2/20 0.37
TSHR P16473 1/20 0.37
STAT3 P40763 1/20 0.37
ATM Q13315 1/20 0.37
MAPT P10636 1/20 0.37
SGPL1 O95470 1/20 0.37
POLB P06746 1/20 0.36
KDM4E B2RXH2 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19484179 0.88 RAB9A (0.38) RAB9ASMN1; SMN2NPC1TP53ALDH1A1
SCHEMBL19484173 0.87 RAB9A (0.38) RAB9ASMN1; SMN2NPC1TP53ALDH1A1
SCHEMBL19484227 0.84 RAB9A (0.41) RAB9ASMN1; SMN2NPC1TP53ALDH1A1
SCHEMBL19484180 0.82 KDM4E (0.45) RAB9ASMN1; SMN2NPC1TP53ALDH1A1
SCHEMBL19484230 0.82 RAB9A (0.41) RAB9ASMN1; SMN2NPC1TP53ALDH1A1
SCHEMBL19483794 0.82 THRB (0.51) RAB9ASMN1; SMN2NPC1TP53ALDH1A1
SCHEMBL19484165 0.79 SLC6A5 (0.46) RAB9ASMN1; SMN2NPC1TP53ALDH1A1
SCHEMBL19484194 0.79 RAB9A (0.50) RAB9ASMN1; SMN2NPC1TP53ALDH1A1
SCHEMBL19484164 0.79 SLC6A5 (0.41) RAB9ASMN1; SMN2NPC1TP53ALDH1A1
SCHEMBL19484167 0.79 RAB9A (0.42) RAB9ASMN1; SMN2NPC1TP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170295789-A1 AMIDE COMPOUND AND USE OF SAME FOR NOXIOUS ARTHROPOD CONTROL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170295789-A1 AMIDE COMPOUND AND USE OF SAME FOR NOXIOUS ARTHROPOD CONTROL OPRM1, TRPA1, L3MBTL3 RAB9A 753/4885SMN1; SMN2 1274/4885NPC1 3696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.